Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: A report from the Pediatric Brain Tumor Consortium (PBTC)

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 9, 2008, Pages 1651-1658

  Williams, Gethin ^a   Fahey, Frederic H ^a   Treves, S Ted ^a   Kocak, Mehmet ^b   Pollack, Ian F ^c   Boyett, James M ^b   Kun, Larry E ^b   Poussaint, Tina Young ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Anaplastic astrocytoma; FDG; MR; Pediatric; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM; IMATINIB;

ADOLESCENT; ARTICLE; ATTENUATION; BRAIN TUMOR; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATIONAL STUDY; FEASIBILITY STUDY; FEMALE; GLIOBLASTOMA; GRAY MATTER; HUMAN; LIQUID; MALE; MEDICAL INFORMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRICS; PHASE 1 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; THREE DIMENSIONAL IMAGING; TUMOR VOLUME; VALIDATION STUDY; WHITE MATTER;

ADOLESCENT; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS, PHASE I AS TOPIC; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; ORGANIZATIONS; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RECURRENCE; SURVIVAL RATE;

EID: 50449091046     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0780-7     Document Type: Article

References (17)

1. J Barentsz S Takahashi W Oyen R Mus P De Mulder R Reznek 2006 Commonly used imaging techniques for diagnosis and staging J Clin Oncol 24 3234 44
2. PJ Ell 2006 The contribution of PET/CT to improved patient management Br J Radiol 79 32 6
3. AF Shields 2006 Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology Mol Imaging Biol 8 141 50
4. TZ Wong GJ van der Westhuizen RE Coleman 2002 Positron emission tomography imaging of brain tumors Neuroimaging Clin N Am 12 615 26
5. L Borgwardt L Hojgaard H Carstensen H Laursen M Nowak C Thomsen 2005 Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion J Clin Oncol 23 3030 7
6. IF Pollack RI Jakacki SM Blaney ML Hancock MW Kieran P Phillips 2007 Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report Neuro-oncology 9 145 60
7. TY Poussaint PC Phillips S Vajapeyam FH Fahey RL Robertson S Osganian 2007 The Neuroimaging Center of the Pediatric Brain Tumor Consortium- collaborative neuroimaging in pediatric brain tumor research: a work in progress Am J Neuroradiol 28 603 7
8. J West JM Fitzpatrick MY Wang BM Dawant CR Maurer Jr. RM Kessler 1997 Comparison and evaluation of retrospective intermodality brain image registration techniques J Comput Assist Tomogr 21 554 66
9. D Delbeke C Meyerowitz RL Lapidus RJ Maciunas MT Jennings PL Moots 1995 Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET Radiology 195 47 52
10. G Di Chiro J Hatazawa DA Katz HV Rizzoli DJ De Michele 1987 Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study Radiology 164 521 6
11. G Di Chiro RL DeLaPaz RA Brooks L Sokoloff PL Kornblith BH Smith 1982 Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography Neurology 32 1323 9
12. NJ Patronas G Di Chiro C Kufta D Bairamian PL Kornblith R Simon 1985 Prediction of survival in glioma patients by means of positron emission tomography J Neurosurg 62 816 22
13. MV Padma S Said M Jacobs DR Hwang K Dunigan M Satter 2003 Prediction of pathology and survival by FDG PET in gliomas J Neurooncol 64 227 37
14. O De Witte M Levivier P Violon I Salmon P Damhaut D Wikler Jr. 1996 Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma Neurosurgery 39 470 6 discussion 76-7
15. O De Witte F Lefranc M Levivier I Salmon J Brotchi S Goldman 2000 FDG-PET as a prognostic factor in high-grade astrocytoma J Neurooncol 49 157 63
16. U Salman C Martin L Hammond K Chintapalli L Denis J Kuhn 2000 9:15-9:30. Use of a Spherical 3-D Blob Analysis Program as a Method of Determination of Standardized Uptake Value (SUV) for Following Tumor Response to Chemotherapeutic Agents (CTA) Clin Positron Imaging 3 152
17. Paldino M, Barboriak D, Wong TZ, Reardon D, Friedman H. Correlation of registered quantitative 18-F-FDG-PET and contrast-enhanced MR imaging findings with survival in patients undergoing intracavitary radiation therapy for high grade glioma. In: RSNA 2006. Chicago, IL; 2006.